Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $293.1 million.

  • Bio-Techne's Accumulated Depreciation & Amortization rose 843.32% to $293.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $293.1 million, marking a year-over-year increase of 843.32%. This contributed to the annual value of $286.1 million for FY2025, which is 1152.77% up from last year.
  • As of Q4 2025, Bio-Techne's Accumulated Depreciation & Amortization stood at $293.1 million, which was up 843.32% from $289.0 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Accumulated Depreciation & Amortization ranged from a high of $293.1 million in Q4 2025 and a low of $186.9 million during Q1 2021
  • In the last 5 years, Bio-Techne's Accumulated Depreciation & Amortization had a median value of $237.3 million in 2023 and averaged $238.6 million.
  • Per our database at Business Quant, Bio-Techne's Accumulated Depreciation & Amortization skyrocketed by 1236.15% in 2021 and then soared by 843.32% in 2025.
  • Over the past 5 years, Bio-Techne's Accumulated Depreciation & Amortization (Quarter) stood at $201.1 million in 2021, then rose by 11.07% to $223.3 million in 2022, then increased by 9.79% to $245.2 million in 2023, then increased by 10.24% to $270.3 million in 2024, then rose by 8.43% to $293.1 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $293.1 million for Q4 2025, versus $289.0 million for Q3 2025 and $286.1 million for Q2 2025.